Genus
GNS · Main Market · Health Care · mcap £1,490m · 2288.0p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 12 Oct 26 | Routine | Transaction in Own Shares | |
| 09 Oct 26 | Results | Annual Report and Annual General Meeting
Annual Report 2026 and Notice of AGM sent to shareholders; AGM scheduled for 18 November 2026. |
+2.6% |
| 05 Oct 26 | Routine | Transaction in Own Shares | |
| 01 Oct 26 | Routine | Total Voting Rights | |
| 30 Sep 26 | Routine | Issue of Equity | |
| 28 Sep 26 | Routine | Admission to Trading | |
| 28 Sep 26 | Routine | Transaction in Own Shares | |
| 21 Sep 26 | Routine | Transaction in Own Shares | |
| 17 Sep 26 | Director dealing | Director/PDMR Shareholding | |
| 16 Sep 26 | Director dealing | Director/PDMR Shareholding | |
| 14 Sep 26 | Holding | Holding(s) in Company | |
| 14 Sep 26 | Routine | Transaction in Own Shares | |
| 10 Sep 26 | Share Buyback Programme
Genus announces £60 million share buyback programme expected to conclude in H2 FY27. |
−3.3% | |
| 10 Sep 26 | Results | Final Results
FY26 adjusted PBT grew 35% to £100.2m; £60m buyback announced; PIC China joint venture formed. |
−3.3% |
| 03 Aug 26 | Routine | Total Voting Rights | |
| 14 Jul 26 | Trading update | FY26 Trading Update – Ahead of expectations
FY26 results ahead of consensus at £98m adjusted PBT; net leverage reduced to 0.4x after £111m BCA cash received. |
+3.7% |
| 29 Jun 26 | Director dealing | Director/PDMR Shareholding | |
| 16 Jun 26 | Holding | Holding(s) in Company | |
| 13 May 26 | Director dealing | Director/PDMR Shareholding | |
| 01 May 26 | Routine | Total Voting Rights | |
| 13 Apr 26 | Director dealing | Director/PDMR Shareholding | |
| 01 Apr 26 | Director dealing | Director/PDMR Shareholding | |
| 10 Mar 26 | Holding | Holding(s) in Company | |
| 04 Mar 26 | Director dealing | Director/PDMR Shareholding | |
| 04 Mar 26 | Director Declaration
Genus plc (LSE: GNS) today announces that Lysanne Gray, Non-Executive Director, has been appointed as a Non-Executive Director of Johnson Service Group plc, a FTSE 250 listed company that provides textile rental and rela |
−2.1% | |
| 27 Feb 26 | Director dealing | Director/PDMR Shareholding | |
| 26 Feb 26 | Results | Half-year Results
H1 25 adjusted operating profit increased 38% to £55.8m; formed Chinese porcine joint venture post-period |
−10.4% |
| 02 Feb 26 | Routine | Block Listing Return | |
| 02 Feb 26 | Routine | Total Voting Rights | |
| 02 Feb 26 | Successful formation of Chinese porcine JV
Genus completes formation of Chinese porcine joint venture with Beijing Capital Agribusiness, receiving US$160m gross cash. |
−6.2% | |
| 23 Jan 26 | PRP Regulatory Progress – Canada
Canada approves PRP gene edit for PRRS-resistant pigs; further approvals needed in Mexico, Japan and China. |
+0.5% | |
| 16 Jan 26 | Trading update | Half Year Trading Update – Ahead of expectations
H1 FY26 adjusted profit before tax approximately £50m excluding BCA milestone, ahead of expectations. |
+7.8% |
| 27 Nov 25 | Director dealing | Director/PDMR Shareholding | |
| 19 Nov 25 | Result of AGM
Genus plc (the 'Company') - 2025 AGM Poll Results |
+8.8% | |
| 19 Nov 25 | Board change | Non-Executive Director Appointments
Dr Celia Baxter appointed Non-Executive Director effective 19 November 2025; Dr Robert Reiter appointed effective 1 January 2026. |
+8.8% |
| 19 Nov 25 | Trading update | AGM Trading Update
Genus reports strong start to FY26 with PIC growth across all regions; Group profit expected modestly ahead of market midpoint. |
+8.8% |
| 03 Nov 25 | Routine | Total Voting Rights | |
| 14 Oct 25 | Holding | Holding(s) in Company | |
| 10 Oct 25 | Routine | Notice of AGM |
Company filings. Not investment advice.